Background. This article summarizes the 2012 European Renal Association-European Dialysis and Transplant Association Registry Annual Report (available at www.era-edta-reg.org) with a specific focus on older patients (defined as ≥65 years). Methods. Data provided by 45 national or regional renal registries in 30 countries in Europe and bordering the Mediterranean Sea were used. Individual patient level data were received from 31 renal registries, whereas 14 renal registries contributed data in an aggregated form. The incidence, prevalence and survival probabilities of patients with end-stage renal disease (ESRD) receiving renal replacement therapy (RRT) and renal transplantation rates for 2012 are presented. Results. In 2012, the overall unadjusted incidence rate of patients with ESRD receiving RRT was 109.6 per million population ( pmp) (n = 69 035), ranging from 219.9 pmp in Portugal to 24.2 pmp in Montenegro. The proportion of incident patients ≥75 years varied from 15 to 44% between countries. The overall unadjusted prevalence on 31 December 2012 was 716.7 pmp (n = 451 270), ranging from 1670.2 pmp in Portugal to 146.7 pmp in the Ukraine. The proportion of prevalent patients ≥75 years varied from 11 to 32% between countries. The overall renal transplantation rate in 2012 was 28.3 pmp (n = 15 673), with the highest rate seen in the Spanish region of Catalonia. The proportion of patients ≥65 years receiving a transplant ranged from 0 to 35%. Five-year adjusted survival for all RRT patients was 59.7% (95% confidence interval, CI: 59.3-60.0) which fell to 39.3% (95% CI: 38.7-39.9) in patients 65-74 years and 21.3% (95% CI: 20.8-21.9) in patients ≥75 years.
Introduction
The European Renal Association-European Dialysis and Transplant Association (ERA-EDTA) Registry annually collects data on renal replacement therapy (RRT) for end-stage renal disease (ESRD) from national and regional renal registries in Europe and those bordering the Mediterranean Sea. In this article, we provide a summary of the 2012 ERA-EDTA Registry Annual Report (available at www.era-edta-reg.org) on the incidence and prevalence of ESRD patients receiving RRT, on kidney transplant rates and on patient and graft survival. As the older patient (defined in this article as 65 years and over and presented in two age groups, i.e. 65-74 years, and 75 years and over) now represents 42% of the RRT population within Europe, this article will pay particular attention to this patient group.
Materials and methods
In 2014, the ERA-EDTA Registry received the 2012 data from the national and regional renal registries in 30 countries in Europe and those bordering the Mediterranean Sea ( Figure 1A ). Data sets with individual patient data were received from 31 national or regional renal registries in 17 countries, whereas 14 national renal registries contributed data in an aggregated form. The percentage coverage of the general population by the renal registries was >98% for all participating countries with the exception of Romania (96%), Latvia (85%) and Georgia (63.5%). The total coverage of the European population by the ERA-EDTA Registry in 2012 was 71.3%. A list of the European countries with available data and those without is provided in Appendix 1.
The RRT incidence and prevalence data were presented as unadjusted rates and standardized for the age and sex distribution of the EU27 population in 2010 [1] . Patient survival on RRT and dialysis were based on incident RRT patients. Patient and graft survival post-transplantation only included patients receiving their first renal transplant between 2003 and 2007 or 2006 and 2010 . The survival analyses were based solely on data from renal registries providing individual patient records. A detailed description of the methods on patient and graft survival is given in Appendix 1. More detailed data than those presented in this current paper were published in the full 2012 ERA-EDTA Registry Annual Report [2] , which is also available online at www.era-edta-reg.org.
The incidence of RRT for ESRD
In 2012, the total number of patients starting RRT for ESRD among all the registries reporting to the ERA-EDTA Registry was 69 035. These registries covered a total population of 629.7 million, resulting in an unadjusted incidence rate of 109.6 per million population (pmp). Figure 1A and Figure 2 show the incidence of ESRD patients receiving RRT per pmp on Day 1, among all national and regional renal registries in 30 countries reporting to the ERA-EDTA Registry in 2012. The highest unadjusted incidence rates were reported in Portugal (219.9 pmp), Greece (209.7 pmp) and Georgia (199.6 pmp) , whereas the lowest unadjusted incidence rates were reported in Montenegro (24.2 pmp), Ukraine (27.6 pmp) and Russia (48.1 pmp). The incidence rate standardized for the EU27 population was highest in Israel (280.5 pmp), Georgia (227.5 pmp) and French-speaking Belgium (201.1 pmp). The mean age at the start of RRT across Europe was 62.0 years in the renal registries providing individual level patient data and 58.2 years in the renal registries providing aggregated data ( Figure 2 ). Figure 1B and Figure 3 provide information on the incidence of RRT, per million age-related population (pmarp), on Day 1 for older patients. For the countries providing individual level data; the incidence of RRT for patients aged 65-74 years or 75 years and over varied considerably between the renal registries ( Figure 3 ). The lowest incidence rate of patients aged 65-74 and 75 years and over was reported in Finland (199.8 and 220.8 pmarp, respectively) . A more than three times as high incidence rate was reported in French-speaking Belgium (619.4 pmarp) for patients aged 65-74 years and Dutchspeaking Belgium (893.6 pmarp) for patients aged over 75 years ( Figure 3 ). Within each country or region, there was a wide variation in the proportion of ESRD patients aged 75 Fig. 1 . (A) The unadjusted incidence of ESRD patients on RRT, pmp on Day 1, among all national and regional renal registries in 30 countries reporting to the ERA-EDTA Registry in 2012. The incidence data for Czech Republic and Slovakia include dialysis patients only. Dutch-and French-speaking Belgium, the Spanish regions of Cantabria, Castile and León and Castile-La Mancha and the UK; England, Northern Ireland and Wales do not report on patients younger than 20 years. (B) The unadjusted incidence of ESRD patients aged 75 years and older on RRT, per million age-related population (pmarp) at Day 1, among all national and regional renal registries in 17 countries providing individual level data to the ERA-EDTA Registry in 2012. B&H: Bosnia-Herzegovina; ME: Montenegro. years and over commencing RRT with the highest proportion reported in Dutch-speaking Belgium (44%) and Greece (43%) and the lowest proportion in Romania (15%) and Serbia (15%). Within the countries supplying individual level data, the four national or regional registries with the highest adjusted incidence of RRT on Day 1 (Greece, French-and Dutchspeaking Belgium and France) also had the highest incidence of RRT on Day 1 for patients 75 years and over ( Figure 1A -B and 3). Table 1 presents the unadjusted incidence of RRT pmp on Day 91, by treatment modality (haemodialysis, peritoneal dialysis and transplantation) for the renal registries providing individual and aggregated data. The incidence rate of haemodialysis was highest in Portugal (184.7 pmp), Greece (171.0 pmp) and Israel (153.7 pmp), whereas the incidence rate of peritoneal dialysis was highest in the Spanish regions of Asturias (38.2 pmp) and Galicia (32.9 pmp) and Sweden (32.6 pmp). The incidence rate of renal transplants on Day 91 was highest in Norway (16.5 pmp), the Netherlands (14.9 pmp) and Iceland (12.5 pmp). Table 2 presents the percentage of patients by established treatment modality (haemodialysis, peritoneal dialysis and transplantation) on Day 91 after the start of RRT, by age group. For patients 75 years and over, the vast majority were treated with haemodialysis, and almost no patients had a kidney transplant. Notably, within this age group the Scandinavian countries (Norway, Sweden, Finland and Denmark) had the highest percentage (about a quarter) of patients treated with peritoneal dialysis.
For children (aged 0-19 years), we performed a separate analysis of the incidence rate by age group and initial treatment modality from a selected number of renal registries which are presented in Table 3 . A more detailed overview of the paediatric RRT data in Europe can be found at www.espn-reg.org.
The prevalence of RRT for ESRD
On the 31 December 2012, a total of 451 270 patients with ESRD were receiving RRT among the renal registries reporting to the ERA-EDTA Registry, corresponding to an unadjusted prevalence of 716.7 pmp. There was a substantial difference in the prevalence pmp throughout Europe, both in the unadjusted prevalence and the prevalence standardized for the age and sex distribution of the EU27 population (Figure 4 ). The unadjusted prevalence was highest in Portugal (1670.2 pmp), French-and Dutchspeaking Belgium (1251.3 and 1206.2 pmp, respectively), whereas the unadjusted prevalence was lowest in Ukraine (146.7 pmp), Russia (213.9 pmp) and Montenegro (309.7 pmp). The prevalence pmp standardized to the EU27 was highest in French-speaking Belgium (1324.1 pmp) and the Spanish regions of Murcia (1303.1 pmp) and Catalonia (1221.3 pmp). In 2012, the mean age of the prevalent RRT patients was 60.3 years within the renal registries providing individual level patient data and 56.6 years within the renal registries providing aggregated data, with considerable variation across renal registries (Figure 4 ).
The unadjusted prevalence of patients aged 65-74 years and 75 years and over was 2400.2 and 2388.9 pmarp, respectively, within the renal registries providing individual level patient data ( Figure 5 ). Prevalent patients aged 65-74 years formed 22% of the total prevalent patient population from these registries and patients aged 75 years and over formed 20%. The prevalence pmarp for patients aged 65-74 years was highest in French-speaking Belgium (3654.2 pmarp) and the Spanish regions of Murcia (3501.5 pmarp) and Catalonia (3382.4 pmarp). The prevalence pmarp for patients aged 75 years and above was highest in French-and Dutch-speaking Belgium (4262.6 and 4093.8 pmarp, respectively) and the Spanish region of Murcia (3701.5 pmarp). Table 4 presents the unadjusted prevalence of ESRD patients receiving RRT pmp on 31st December 2012, by treatment modality (haemodialysis, peritoneal dialysis and transplantation) for the renal registries providing individual and aggregated data. The prevalence of haemodialysis was highest in Portugal (997.6 pmp), Greece (844.4 pmp) and Israel (691.0 pmp), whereas the prevalence of peritoneal dialysis was highest in the Spanish regions of Galicia (97.6 pmp), Asturias (96.8 pmp) and Basque country (92.6 pmp). The prevalence of patients living with a functioning renal transplant was highest in the Spanish regions of Basque country (670.8 pmp) and Catalonia The incident counts at Day 91, on which the data presented in this table are based, are estimated (see annual report for methods). (659.1 pmp) and Norway (639.2 pmp). Table 5 presents the percentage of patients by established treatment modality (haemodialysis, peritoneal dialysis and transplantation) on 31st December 2012, by age group. For prevalent patients 75 years and over, the percentage of patients receiving haemodialysis varied from 54% in Finland to 98% in Slovenia. In this age group, the percentage of patients receiving peritoneal dialysis was highest in Denmark (16%) and Sweden (15%), whereas Norway reported the highest number of patients living with a functioning kidney allograft (38%). These results were based only on countries with <10% missing values for treatment modality.
The prevalence of children with ESRD by age group and treatment modality is presented in Table 6 . Overall on the 31 December 2012 the prevalence of children with ESRD was 54.7 pmarp: the majority (41.5 pmarp) had a functioning renal transplant whereas 8.1 pmarp were receiving haemodialysis and 4.6 pmarp peritoneal dialysis. 
Renal transplants in 2012
During 2012 there were a total of 15 673 renal transplants performed within the countries and regions reporting to the ERA-EDTA Registry, corresponding to a renal transplantation rate of 28.3 pmp (Figure 6 ). Of these 12 252 were from a deceased donor source (22.1 pmp, 78%) and 3322 renal transplants were from a living donor source (6.0 pmp, 21%). The kidney transplantation rate varied considerably between the countries and regions reporting to the ERA-EDTA Registry, with the highest rates pmp seen in the Spanish regions of Catalonia and Cantabria (74.0 and 60.9 pmp, respectively) and in Northern Ireland (64.2 pmp). The proportion of living donor to deceased donor transplants also varied considerably within each country and region ( Figure 6 ). Notably, for the countries with a transplantation rate >20.0 pmp, Israel and the Netherlands were the only two countries with a higher proportion of living to deceased donor renal transplants (1.54 and 1.03, respectively).
The mean age at renal transplantation (available from the renal registries supplying individual level data and The overall prevalence of RRT is underestimated by ∼3% due to an estimated 30% underreporting of patients living with a functioning graft. c Data include dialysis patients only. When cells are left empty, the data are unavailable. Serbia  66  8  14  12  32  13  48  6  40  6  39  15  66  7  12  14  80  10  1  8  83  9  0  8  Slovenia  67  2  31  0  29  14  57  0  40  4  56  0  56  3  41  0  74  2  24  0  98  1  1  0  Spain  Andalusia  45  4  51  0  9  3  88  0  27  4  69  0  33  4  63  0  52  4  44  0  83  5  12  0  Aragon  39  4  57  0  13  0  88  0  19  8  73  0  27  3  69  0  42  6  51  0  68  2  29  0  Asturias  35  9  55  0  13  25  63  0  21  11  67  0  23  10  67  0  35  6  59  0  64  9  27  0  Basque country  33  8  59  0  3  6  90  0  21  7  72  0  22  10  68  0  34  7  59  0  65  7  28  0  Cantabria   a   35  7  58  25  2  73  0  22  8  70  0  36  6  58  0  71  10  19  0  Castile and León   a   41  7  52  1  23  5  71  1  25  6  69  0  38  7  54  0  72  8  18  2  Castile-La Mancha   a   39  6  54  1  17  10  73  0  30  6  64  0  40  5  55  1  71  3  26  1  Catalonia  25  4  55  16  6  5  88  2  13  3  76  8  17  4  66  12  25  5  53  17  48  3  22  27  Extremadura  45  6  44  4  0  0  100  0  28  10  56  6  30  7  57  5  52  4  40  4  84  4  12  0  Galicia  45  8  47  0  11  28  61  0  24  8  68  0  31  10  60  0  49  6  45  0  81  8  12  0  Community of Madrid  38  6  56  0  11  8  81  0  20  8  72  0  27  6  66  0  41  5  54  0  71  3  26  0  Region of Murcia  54  4  42  0  10  20  70  0  33  7  61  0  36  4  60  0  62  4  34  0  92  3  6  0  Valencian Region  54  5  40  0  17  11  72  0  33  7  61  0  41  6  52  0  56  5  39  0  88  4  8  0  Sweden  34  9  57  0  8  9  83  0  20  5  75  0  25  7  68  0  38  11  52  0  69  15  15  0  The Netherlands  35  6  58  0  6  5  89  0  20  4  77  0  24  6  70  0  38  7  54  0  74  9 The overall prevalence of RRT is underestimated by ∼3% due to an estimated 30% underreporting of patients living with a functioning graft.
limited to adult patients) was 51.9 years ( Figure 6 ). The mean recipient age at the time of renal transplantation was greatest in the Spanish regions of Aragon (57.0 years) and Asturias (55.7 years) and Norway (55.1 years). The youngest mean recipient ages at the point of renal transplantation were reported by Romania (38.7 years), Bosnia Table 7 . Adjustments were made for age, gender and the distribution of primary renal disease (see Appendix 1) . Five-year survival for all RRT patients was 59.7% (95% confidence interval, CI: 59.3-60.0) which fell to 39.3% (95% CI: 38.7-39.9) in patients 65-74 years and 21.3% (95% CI: 20.8-21.9) in patients over 75 years.
Affiliated registries
